Asthonea Labs IPO Set to Open May 27, Eyeing ₹37.67 Crore for Expansion and Working Capital
Asthonea Labs Ltd., a pharmaceutical and cosmetic contract manufacturer, is poised to launch its initial public offering (IPO) on May 27, 2025, with the aim of raising up to ₹37.67 crore. The book-building issue, entirely a fresh issue of 27.90 lakh shares, will close on May 29, 2025. The company plans to utilize the funds for significant expansion, including setting up new manufacturing facilities and bolstering working capital.
Asthonea Labs IPO Price-band & Lot Size
The IPO price band has been fixed at ₹128 to ₹135 per equity share, with a face value of ₹10 per share. Investors can bid for a minimum of 1000 shares, translating to a minimum investment of ₹1,28,000 for retail investors. High Net Worth Individuals (HNIs) can apply for a minimum of 2 lots, or 2,000 shares, amounting to ₹2,70,000.
More Details About Asthonea Labs
Asthonea Labs, incorporated in 2017, is a prominent player in the contract manufacturing of pharmaceutical and cosmetic products for both domestic and international markets. The company manufactures a diverse range of products, including antibiotics, anti-cold medicines, antihistamines, and treatments for various health issues, as well as skin, tooth, and hair care products. They also trade in packaging and raw materials. Notably, Asthonea Labs plans to launch its own brands “Glow Up” and “Regero,” and expand its export reach to countries like Iraq and Yemen, with “Avicel” as a planned launch.
Asthonea Labs IPO Objectives
The Asthonea Labs IPO proceeds are earmarked for several key objectives:
* ₹12.90 million for expenses related to registration in Bolivia, South America.
* ₹52.34 million for the purchase and installation of plant and machinery for ointment production for export purposes.
* ₹49.52 million for advertising, marketing, and brand building.
* ₹6.84 million for investment in procuring hardware and software.
* ₹197.50 million for funding working capital requirements.
* The remaining funds will be allocated for general corporate purposes.
Asthnea Labs IPO Key Dates
The tentative allotment for the Asthonea Labs IPO is expected to be finalized on Friday, May 30, 2025. Refunds are slated to be initiated on Monday, June 2, 2025, with shares credited to Demat accounts on the same day. The company is expected to list on the BSE SME platform with a tentative listing date of Tuesday, June 3, 2025.
Asthonea Labs Promoter
Ashish Gulati is the promoter of Asthonea Labs. The shareholding pre-issue stands at 98.42%.
Asthonea Labs Financial
For investors considering the IPO, the company’s financials show a consistent growth trend. As of December 31, 2024, Asthonea Labs reported assets of ₹96.52 crore, revenue of ₹69.69 crore, and a profit after tax of ₹4.10 crore. Net worth stood at ₹17.28 crore, with total borrowings at ₹49.48 crore.
Asthonea Labs IPO Registrar & Lead Manager
Oneview Corporate Advisors Pvt. Ltd. is the book-running lead manager for the IPO, while Kfin Technologies Limited will serve as the registrar. Investors can confirm their UPI mandates until 5 PM on May 29, 2025.
Disclaimer: This content is about intended solely for educational and informational purposes and should not be interpreted as financial or investment advice. The information presented is derived from publicly available sources and independent analysis; however, its accuracy or completeness is not guaranteed. Readers are encouraged to conduct their own due diligence and seek guidance from a professional financial advisor before making any investment decisions. Neither the author nor stoxmail.com assumes responsibility for any financial losses or investment actions taken based on this article.